Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Adaptimmune Therapeutics PLC | Director | Option to purchase Ordinary Shares | 660K | Jul 1, 2024 | Direct | ||
Vaxcyte, Inc. | Director | Stock Option (right to buy) | 16.8K | Jul 2, 2024 | Direct | ||
Vaxcyte, Inc. | Director | No securities owned. | 0 | Jul 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PCVX | Vaxcyte, Inc. | Jul 2, 2024 | 1 | $0 | 4 | Jul 3, 2024 | Director |
PCVX | Vaxcyte, Inc. | Jul 2, 2024 | 0 | $0 | 3 | Jul 3, 2024 | Director |
ADAP | Adaptimmune Therapeutics PLC | Jul 1, 2024 | 1 | $0 | 4 | Jul 1, 2024 | Director |
ADAP | Adaptimmune Therapeutics PLC | Jul 3, 2023 | 1 | $0 | 4 | Jul 3, 2023 | Director |
ADAP | Adaptimmune Therapeutics PLC | Jul 1, 2022 | 1 | $0 | 4 | Jul 1, 2022 | Director |
ADAP | Adaptimmune Therapeutics PLC | Jul 1, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Director |